New IMWG consensus statement published on the role of 18F-FDG PET/CT in myeloma
The International Myeloma Working Group (IMWG) has published a consensus statement providing recommendations for the best use of 18-fluorodeoxyglucose (18F-FDG) PET/CT in the diagnosis and management of myeloma patients. Published in the Lancet Oncology, they consider this technique to be valuable not only in the initial work up for newly diagnosed myeloma patients but also…